Augmenting Glioblastoma Chemotherapy with Polymers

Matthew Skinner, Sarah M. Ward, Carol L. Nilsson, Todd Emrick

Research output: Contribution to journalReview article

Abstract

Chemotherapeutics are vital for treating brain tumors such as glioblastoma, an aggressive and prolific cancer predominantly treated with DNA alkylating agents. The efficacy of antiglioblastoma drugs, such as temozolomide, is limited by their rapid clearance and instability under normal physiological conditions. Both local and systemic polymer-based therapeutics have shown promise for treating many cancers, and as such there is a growing interest in applying polymer techniques to augment the efficacy and stability of glioblastoma chemotherapeutics. Notably, brain tumor chemotherapy presents unique challenges and will require tailored delivery systems to develop markedly improved treatments.

Original languageEnglish (US)
Pages (from-to)8-10
Number of pages3
JournalACS Chemical Neuroscience
Volume9
Issue number1
DOIs
StatePublished - Jan 17 2018
Externally publishedYes

Fingerprint

Chemotherapy
temozolomide
Glioblastoma
Brain Neoplasms
Tumors
Brain
Polymers
Drug Therapy
Alkylating Agents
Neoplasms
DNA
Therapeutics
Pharmaceutical Preparations

Keywords

  • brain tumor
  • chemotherapy
  • Glioblastoma

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

Augmenting Glioblastoma Chemotherapy with Polymers. / Skinner, Matthew; Ward, Sarah M.; Nilsson, Carol L.; Emrick, Todd.

In: ACS Chemical Neuroscience, Vol. 9, No. 1, 17.01.2018, p. 8-10.

Research output: Contribution to journalReview article

Skinner, M, Ward, SM, Nilsson, CL & Emrick, T 2018, 'Augmenting Glioblastoma Chemotherapy with Polymers', ACS Chemical Neuroscience, vol. 9, no. 1, pp. 8-10. https://doi.org/10.1021/acschemneuro.7b00168
Skinner, Matthew ; Ward, Sarah M. ; Nilsson, Carol L. ; Emrick, Todd. / Augmenting Glioblastoma Chemotherapy with Polymers. In: ACS Chemical Neuroscience. 2018 ; Vol. 9, No. 1. pp. 8-10.
@article{32200520af52437695ea907e6f798542,
title = "Augmenting Glioblastoma Chemotherapy with Polymers",
abstract = "Chemotherapeutics are vital for treating brain tumors such as glioblastoma, an aggressive and prolific cancer predominantly treated with DNA alkylating agents. The efficacy of antiglioblastoma drugs, such as temozolomide, is limited by their rapid clearance and instability under normal physiological conditions. Both local and systemic polymer-based therapeutics have shown promise for treating many cancers, and as such there is a growing interest in applying polymer techniques to augment the efficacy and stability of glioblastoma chemotherapeutics. Notably, brain tumor chemotherapy presents unique challenges and will require tailored delivery systems to develop markedly improved treatments.",
keywords = "brain tumor, chemotherapy, Glioblastoma",
author = "Matthew Skinner and Ward, {Sarah M.} and Nilsson, {Carol L.} and Todd Emrick",
year = "2018",
month = "1",
day = "17",
doi = "10.1021/acschemneuro.7b00168",
language = "English (US)",
volume = "9",
pages = "8--10",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "1",

}

TY - JOUR

T1 - Augmenting Glioblastoma Chemotherapy with Polymers

AU - Skinner, Matthew

AU - Ward, Sarah M.

AU - Nilsson, Carol L.

AU - Emrick, Todd

PY - 2018/1/17

Y1 - 2018/1/17

N2 - Chemotherapeutics are vital for treating brain tumors such as glioblastoma, an aggressive and prolific cancer predominantly treated with DNA alkylating agents. The efficacy of antiglioblastoma drugs, such as temozolomide, is limited by their rapid clearance and instability under normal physiological conditions. Both local and systemic polymer-based therapeutics have shown promise for treating many cancers, and as such there is a growing interest in applying polymer techniques to augment the efficacy and stability of glioblastoma chemotherapeutics. Notably, brain tumor chemotherapy presents unique challenges and will require tailored delivery systems to develop markedly improved treatments.

AB - Chemotherapeutics are vital for treating brain tumors such as glioblastoma, an aggressive and prolific cancer predominantly treated with DNA alkylating agents. The efficacy of antiglioblastoma drugs, such as temozolomide, is limited by their rapid clearance and instability under normal physiological conditions. Both local and systemic polymer-based therapeutics have shown promise for treating many cancers, and as such there is a growing interest in applying polymer techniques to augment the efficacy and stability of glioblastoma chemotherapeutics. Notably, brain tumor chemotherapy presents unique challenges and will require tailored delivery systems to develop markedly improved treatments.

KW - brain tumor

KW - chemotherapy

KW - Glioblastoma

UR - http://www.scopus.com/inward/record.url?scp=85040648021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040648021&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.7b00168

DO - 10.1021/acschemneuro.7b00168

M3 - Review article

C2 - 28594164

AN - SCOPUS:85040648021

VL - 9

SP - 8

EP - 10

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 1

ER -